Newsletters

• Download the October Newsletter

  All the latest news and events for MCCC members

See all

In the media

• The short-term effects of daily aspirin use to prevent cancer

  To explore the short-term effects, the ASPREE research program lead by Prof John McNeil of Monash Department of Epidemiology and Preventive Medicine, was involved in a recent study using individual patient data from randomised trials of daily aspirin versus no aspirin in prevention of vascular events. During the trials, results showed taking aspirin daily reduced the number of cancer deaths particularly from five years onwards and resulted in fewer non-vascular deaths overall.

• Examining the effect of metformin in breast cancer

  Dr Kristy Brown, head of the metabolism and cancer laboratory at Prince Henry’s Institute, is facilitating a new trial aimed at examining the effect of metformin, an anti-diabetic drug, to examine the effect on oestrogen biosynthesis in the breast in the preventative and neo-adjuvant settings.

• MCCC welcomes cancer funding

  Earlier this month, the MCCC welcomed the Victorian Coalition Government’s decision to commit $59.6 million over the next four years through the Victorian Cancer Agency (VCA) to fund research into cancer.

See all